Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Neutral Red Solution (0.33%) (AC108)
Cat.#: ASSD-108
Specifications
Description Neutral Red is a Commonly used histological stain that stains lyosomes red. It can also be used as a counterstain with other dyes. It is frequently used as part of the neutral red uptake assay to provide a quantitative estimation of the number of viable cells in a culture. Synonyms Basic Red 5, C.I. Basic Red 5, Neutral Red W, Toluylene red Size 50 mL, 100 mL Chemical Name 3-Amino-7-dimethylamino-2-methylphenazine hydrochloride Molecule Weight 288.78 Molecular formula C15H17N4Cl CAS Number 553-24-2 PubChem identifier 11105 MDL Number MFCD00012651 Solubility Soluble in water Storage Store at 4° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-196 5-Carboxyfluorescein (AC196) 100 mg, 250 mg inquiry ASSD-211 5(6)-Carboxyfluorescein N-hydroxysuccinimide ester (AC211) 100 mg, 1 g inquiry ASSD-171 Ionomycin calcium salt (AC171) 1mg, 5mg inquiry ASSD-126 Fluorescent H2 antagonist [aminopotentidine] (AC126) 50 μg inquiry ASSD-113 Thionin acetate salt (AC113) 5 g inquiry ASSD-158 Eosin Y (AC158) 1g inquiry ASSD-162 Nile Red (AC162) 25 mg inquiry ASSD-194 7-(Diethylamino)coumarin-3-carboxylic acid (AC194) 100 mg inquiry ASSD-122 Fluorescent β2 antagonist [(±)-propranolol] (AC122) 500 μg inquiry ASSD-215 1-Pyrenylmethyl Methanethiosulfonate (AC215) 10 mg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket